The role of inflammation in CNS injury and disease
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
For many years, the central nervous system (CNS) was considered to be ‘immune privileged’, neither susceptible to nor contributing to inflammation. It is now appreciated that the CNS does exhibit features of inflammation, and in response to injury, infection or disease, resident CNS cells generate inflammatory mediators, including proinflammatory cytokines, prostaglandins, free radicals and complement, which in turn induce chemokines and adhesion molecules, recruit immune cells, and activate glial cells. Much of the key evidence demonstrating that inflammation and inflammatory mediators contribute to acute, chronic and psychiatric CNS disorders is summarised in this review. However, inflammatory mediators may have dual roles, with detrimental acute effects but beneficial effects in long‐term repair and recovery, leading to complications in their application as novel therapies. These may be avoided in acute diseases in which treatment administration might be relatively short‐term. Targeting interleukin (IL)‐1 is a promising novel therapy for stroke and traumatic brain injury, the naturally occurring antagonist (IL‐1ra) being well tolerated by rheumatoid arthritis patients. Chronic disorders represent a greater therapeutic challenge, a problem highlighted in Alzheimer's disease (AD); significant data suggested that anti‐inflammatory agents might reduce the probability of developing AD, or slow its progression, but prospective clinical trials of nonsteroidal anti‐inflammatory drugs or cyclooxygenase inhibitors have been disappointing. The complex interplay between inflammatory mediators, ageing, genetic background, and environmental factors may ultimately regulate the outcome of acute CNS injury and progression of chronic neurodegeneration, and be critical for development of effective therapies for CNS diseases. British Journal of Pharmacology (2006) 147, S232–S240. doi:10.1038/sj.bjp.0706400
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As various neurological and psychiatric diseases have been associated with neuroinflammation in some post-mortem studies,183, 184, 185”
From Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review (2018) · cites this paper as [183]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Stroke is caused by ischaemia, leading to inflammation [900] and to the formation of ROS and other damaging free radicals [901] in the brain”
The cited source says what the claim attributes to it.
In the citing paper
“These processes induce adhesion molecules and, in order, mobilize immune and glial cells in a parallel and synergistic way (94, 126 -128).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [127]
In the citing paper
“Thus, although this is not the focus of the present more physiologically based review, we recognise that many of relationships between ROSs and oxidative stress and overt progressive diseases may be mediated via the inflammatory signalling pathways involved in 'innate immunity' [900,1991-1993].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury
Faulkner, J. R., Herrmann, J. E., Woo, M. J., Tansey, K. E., Doan, N. B., & Sofroniew, M. V. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3547-03.2004 · Cited by 1,598 · cited 1×
“…for repair and recovery, but in fact this increases neuronal loss from the injury site and inhibits repair of the BBB and axonal remyelination (Faulkner et al., 2004), partly because astrocytes produce neurotrophic factors such as nerve growth factor and brain-derived growth factor that are…”
BackgroundMcGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367 · cited 1×
“Although other epidemiological studies also suggest a beneficial role for antiinflammatory agents in AD (McGeer et al., 1996), the general view from prospective trials of nonsteroidal inflammatory drugs (NSAIDs) is that they are disappointingly variable.”
BackgroundTNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,017
Interleukin 1 in the brain: biology, pathology and therapeutic target
Rothwell, N. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01661-1 · Cited by 671 · cited 3×
“IL-1 was discovered as an important endogenous pyrogen, and is now recognised as the ‘prototypic inflammatory cytokine’ (reviewed by Rothwell & Luheshi, 2000).”
BackgroundInfluentialSelf-citationPerry, V. H. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.01.004 · Cited by 560 · cited 2×
“…metalloproteinase and iNOS activities, and breakdown of the BBB. Complications of its use however include inhibition of remyelination in MS models, and observations that microglial activation may be associated with anti-inflammatory cytokine expression rather than proinflammatory (Perry, 2004).”
BackgroundInflammation and the Degenerative Diseases of Aging
McGEER, P. L., & McGEER, E. G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.007 · Cited by 518 · cited 1×
“The complement cascade is activated, and mRNAs for complement proteins are upregulated in PD (and AD) to a greater extent than in peripheral inflammatory diseases such as rheumatoid arthritis (reviewed by McGeer & McGeer, 2004).”
BackgroundScherbel, U., Raghupathi, R., Nakamura, M., Saatman, K. E., Trojanowski, J. Q., Neugebauer, E., Marino, M. W., & McIntosh, T. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8721 · Cited by 415 · cited 1×
“…injury, the TNFa knockout mice show less behavioural impairment than the wild-type controls, but while the wild-type mice recovered in the weeks following injury, the knockout mice did not, remaining significantly impaired both in terms of histological damage and behaviour (Scherbel et al., 1999).”
BackgroundNew Insights into the Biology of the Acute Phase Response
Suffredini, A. F., Fantuzzi, G., Badolato, R., Oppenheim, J. J., & O'Grady, N. P. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020563913045 · Cited by 391 · cited 1×
“This represents another host defence mechanism which can limit proliferation of invading pathogens (Suffredini et al., 1999).”
BackgroundVezzani, A., Moneta, D., Richichi, C., Aliprandi, M., Burrows, S. J., Ravizza, T., Perego, C., & De Simoni, M. G. (2002) · Epilepsia · doi:10.1046/j.1528-1157.43.s.5.14.x · Cited by 386 · cited 1×
“Exogenous IL-1b enhances chemically induced seizures in rats and IL-1ra inhibits motor seizures and delays their onset (see Vezzani et al., 2002).”
Background
Cited by
Items 601–700 of 1,000
Silva, S. P., Zago, A. M., Carvalho, F. B., Germann, L., Colombo, G. D. M., Rahmeier, F. L., Gutierres, J. M., Reschke, C. R., Bagatini, M. D., Assmann, C. E., et al. (2021) · Journal of Immunology Research · doi:10.1155/2021/7497185 · Cited by 35
“Neuroinflammation is considered a hallmark of brain diseases [8].”
Pro‐gliogenic effect of IL‐1α in the differentiation of embryonic neural precursor cells in vitro
Ajmone‐Cat, M. A., Cacci, E., Ragazzoni, Y., Minghetti, L., & Biagioni, S. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06670.x · Cited by 35
Emerging roles of the acute phase protein pentraxin-3 during central nervous system disorders
Rajkovic, I., Dénes, Á., Allan, S. M., & Pinteaux, E. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.12.007 · Cited by 35
“Inflammation is a key hallmark and contributor to all major acute and chronic central nervous system (CNS) disorders, including stroke, brain trauma, Alzheimer's disease (AD) and Parkinson's disease (PD) (Hohlfeld et al., 2007; Lucas et al., 2006).”
BackgroundAssociation Between Serum Levels of Vitamin D and the Risk of Post-Stroke Anxiety
Wu, C., Ren, W., Cheng, J., Zhu, B., Jin, Q., Wang, L., Chen, C., Zhu, L., Chang, Y., Gu, Y., et al. (2016) · Medicine · doi:10.1097/md.0000000000003566 · Cited by 35
Seguella, L., Capuano, R., Sarnelli, G., & Esposito, G. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1612744 · Cited by 35
“cules, cytokines, chemokines, prostaglandins and other cytotoxic mediators that also regulate their own hypertrophy and proliferation [26].”
BackgroundSmith, S. P., Wu, G., Fooks, A. R., K‐C., J., & Banyard, A. C. (2019) · Journal of General Virology · doi:10.1099/jgv.0.001269 · Cited by 35
Astrocytes and ischemic tolerance
Hirayama, Y., & Koizumi, S. (2017) · Neuroscience Research · doi:10.1016/j.neures.2017.11.013 · Cited by 34
“This delayed injury involves several proinflammatory mediators or excitatory transmitters, including cytokines, glutamate, nitric oxide, free radicals, and prostaglandins (Ikeda-Matsuo et al., 2006; Lucas et al., 2006).”
BackgroundNosocomial Infections in the Neurointensive Care Unit
Busl, K. M. (2018) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2017.11.008 · Cited by 34
Inflammation, It’s Regulation and Antiphlogistic Effect of the Cyanogenic Glycoside Amygdalin
Figurová, D., Tokárová, K., Greifová, H., Knížatová, N., Kolesárová, A., & Lukáč, N. (2021) · Molecules · doi:10.3390/molecules26195972 · Cited by 34
“Traditional antiinflammatory drugs acting on its pathway have been shown by their inhibitory effect to increase the risk of serious cardiovascular side effects, an increase in atherothrombotic events, as a result of which, even such selective COX-2 inhibitors were later withdrawn from the pharmaceutical market [79,80].”
BackgroundZuo, J., Zhang, T., Peng, C. Y., Xu, B., Dai, O., Lü, Y., Zhou, Q., & Xiong, L. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117337 · Cited by 34
Zhang, S., Cheng, K., Wang, X., & Yin, H. H. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.08.022 · Cited by 34
Sutherland, T. C., Mathews, K. J., Mao, Y., Nguyen, T., & Gorrie, C. A. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00310 · Cited by 34
“In the case of traumatic SCI, inflammation has been shown to have both neuroprotective and neurotoxic actions (Schwartz et al., 1999; Ekdahl et al., 2003; Popovich and Jones, 2003; Lucas et al., 2006; Hohlfeld et al., 2007; Kigerl et al., 2009; Das et al., 2012).”
BackgroundStem cells for neuroprotection in glaucoma
Bull, N. D., Johnson, T. V., & Martin, K. R. G. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)01135-7 · Cited by 34
Genetic priming of a proinflammatory profile predicts low IQ in octogenarians
Krabbe, K. S., Mortensen, E. L., Avlund, K., Pilegaard, H., Christiansen, L., Pedersen, B. K., Schroll, M., Jørgensen, T., Pedersen, B. K., & Brüünsgaard, H. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.08.013 · Cited by 34
Ribeiro, L. R., Della-Pace, I. D., Ferreira, A. P. D. O., Funck, V. R., Pinton, S., Bobinski, F., de Oliveira, C. V., Fiorin, F. D. S., Duarte, M. M. M. F., Furian, A. F., et al. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.04.008 · Cited by 34
Sawano, T., Watanabe, F., Ishiguchi, M., Doe, N., Furuyama, T., & Inagaki, S. (2015) · Glia · doi:10.1002/glia.22890 · Cited by 33
Bone Fracture Enhances Trauma Brain Injury
Yang, L., Guo, Y., Wen, D., Yang, L., Chen, Y., Zhang, G., & Fan, Z. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12393 · Cited by 33
Pereira, M. G., Cheng, Y., Raukar, N. P., Reagan, J., Quesenberry, M., Goldberg, L. R., Borgovan, T., LaFrance, W. C., Jr., Dooner, M. S., Deregibus, M. C., et al. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.266924 · Cited by 33
Kong, J., Du, Z., & Li, D. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00187-z · Cited by 33
“Upregulation of TNF-α, IL-6, IL-1β, and PGE2 are capable of initiating and amplifying the inflammatory response in brain cells (Lucas et al. 2006).”
Wang, F., Ji, S., Wang, M., Liu, L., Li, Q., Jiang, F., Cen, J., & Ji, B. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173189 · Cited by 33
Shi, G., Li, M., Zhou, R., Wang, X., Xu, W., Yang, F. H., & Xue, S. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-01031-w · Cited by 33
miR-596-3p suppresses brain metastasis of non-small cell lung cancer by modulating YAP1 and IL-8
Li, C., Zheng, H., Xiong, J., Huang, Y., Li, H., Jin, H., Ai, S., Wang, Y., Su, T., Sun, G., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05062-7 · Cited by 33
“In the therapeutic strategy against the permeability of BBB, tumor-induce inflammatory cytokines were frequently used to increase the permeability [29, 30].”
Prottay, A. A. S., Bappi, M. H., Akbor, M. S., Asha, A. I., Bhuia, M. S., Shafin, A. A., Mia, M. N., Mubarak, M. S., Lima, M. D. A., Coutinho, H. D. M., et al. (2023) · Pharmaceutical Science Advances · doi:10.1016/j.pscia.2023.100029 · Cited by 33
Zuo, S., Li, W., Li, Q., Zhao, H., Tang, J., Chen, Q., Liu, X., Zhang, J. H., Chen, Y., & Feng, H. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.10.056 · Cited by 33
Brain involvement in rheumatoid arthritis: A magnetic resonance spectroscopy study
Emmer, B. J., van der Bijl, A. E., Huizinga, T. W. J., Breedveld, F. C., Steens, S. C. A., Bosma, G. P. T., van Buchem, M. A., & van der Grond, J. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24932 · Cited by 33
Discovery and Characterization of Carbamothioylacrylamides As EP2 Selective Antagonists
Ganesh, T., Jiang, J., Shashidharamurthy, R., & Dingledine, R. J. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400112h · Cited by 33
Biasibetti, H., Pierozan, P., Rodrigues, A. F., Manfredini, V., & Wyse, Â. T. D. S. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9866-6 · Cited by 33
“These mediators upregulate adhesion molecules, increase permeability of the blood-brain barrier, facilitating the invasion of peripheral immune cells, inducing the release of potentially toxic molecules that can compromise brain cells [44].”
BackgroundBishnoi, M., Chopra, K., & Kulkarni, S. K. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.033 · Cited by 33
“Increase in the levels of TNF-α after chronic administration of haloperidol is associated with an increase in the activity of nNOS, hence increasing the levels of total nitric oxide (Lucas et al., 2006).”
BackgroundKandeda, A. K., Moto, F. C. O., Mbomo, R. E. A., Omam, J. P. O., Ojong, L. J., & Bum, E. N. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114338 · Cited by 32
Developing Biomarkers of Mild Traumatic Brain Injury: Promise and Progress of CNS-Derived Exosomes
Vaughn, M. N., Winston, C. N., Levin, N., Rissman, R. A., & Risbrough, V. B. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.698206 · Cited by 32
“However, inflammatory mediators have been implicated in both delayed CNS damage, impacting neurological recovery (73).”
BackgroundBalistreri, C. R., Grimaldi, M. P., Vasto, S., Listì, F., Chiappelli, M., Licastro, F., Lio, D., Caruso, C., & Candore, G. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1386.012 · Cited by 32
Berbegall, A. P., Villamón, E., Tadeo, I., Martinsson, T., Cañete, A., Castel, V., Navarro, S., & Noguera, R. (2014) · Neoplasia · doi:10.1016/j.neo.2014.05.012 · Cited by 32
“It is assumed that the host immune response to a human solid tumor could be reflected in immune cell infiltration, and chronic local inflammation has been described as being involved in the initiation of many adult neoplasias [58–62].”
BackgroundZhou, J., Wang, M., & Deng, D. (2019) · Gene · doi:10.1016/j.gene.2019.144277 · Cited by 32
Inflammatory Mediators in the Frontal Lobe of Patients with Mixed and Vascular Dementia
Mulugeta, E., Molina-Holgado, F., Elliott, M. S., Hortobagyi, T., Perry, R., Kalaria, R. N., Ballard, C. G., & Francis, P. T. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000118633 · Cited by 29
“Cytokines and chemokines are primarily secreted by activated microglia and astrocytes during and following acute insults [”
BackgroundPiovan, A., Battaglia, J., Filippini, R., Dalla Costa, V., Facci, L., Argentini, C., Pagetta, A., Giusti, P., & Zusso, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.724993 · Cited by 31
Yang, S., Yang, Y., Chen, C., Wang, H., Ai, Q., Lin, M.-Y., Zeng, Q., Zhang, Y., Gao, Y., Li, X., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.670586 · Cited by 31
Hassanein, E. H. M., Saleh, F. M., Ali, F. E. M., Rashwan, E. K., Atwa, A. M., & El‐Ghafar, O. A. M. A. (2022) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2022.2143371 · Cited by 31
Piezoelectric and Triboelectric Nanogenerators for Enhanced Wound Healing
Jang, H., Tiruneh, D. M., Ryu, H., & Yoon, J. (2023) · Biomimetics · doi:10.3390/biomimetics8070517 · Cited by 31
Zheng, Z., Yuan, R., Song, M., Huo, Y., Liu, W., Cai, X., Zou, H., Chen, C., & Ye, J. (2012) · Brain Research · doi:10.1016/j.brainres.2012.10.014 · Cited by 31
“In fact, nerve injury can produce a large number of local inflammatory factors, which may lead to further nerve damage (Lucas et al., 2006).”
InfluentialAbbasloo, E., Dehghan, F., Khaksari, M., Najafipour, H., Vahidi, R., Dabiri, S., Sepehri, G., & Asadikaram, G. (2016) · Scientific Reports · doi:10.1038/srep31866 · Cited by 31
“(F) TBI+ SKEO200; more neuronal structures and brain parenchyma remained normal; numbered arrows: neuron (1), degeneration of neurons (2), parenchyma (3), neutrophils (4), eosinophils (5) and astrocyte (6).”
BackgroundPerez‐Nievas, B. G., Hammerschmidt, T., Kummer, M. P., Terwel, D., Leza, J. C., & Heneka, M. T. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07083.x · Cited by 31
“Stress exposure modifies the onset and progression of several neuropsychiatric diseases (post-traumatic stress disorder, major depressive disorder, anxiety disorders, schizophrenia) as well as of neurological diseases, like Alzheimer’s disease (AD) (Lucas et al. 2006).”
BackgroundDucruet, A. F., Sosunov, S. A., Zacharia, B. E., Górski, J., Yeh, M. L., DeRosa, P., Cohen, G. H., Gigante, P. R., & Connolly, E. S. (2011) · Translational Stroke Research · doi:10.1007/s12975-011-0104-2 · Cited by 31
“This is particularly relevant for anti-inflammatory strategies, as inflammation contributes to the process of post-ischemic repair at delayed time points [15, 16].”
Anti-Inflammatory and antipyretic effects of an ethanolic extract of Palisota hirsuta K. Schum roots
Boakye‐Gyasi, E., Woode, E., Ainooson, G. K., Obiri, D. D., Ansah, C., Duweijua, M., & Donkoh, A. (2008) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp.9000033 · Cited by 31
Ahmad, S., Elsherbiny, N. M., Bhatia, K., Elsherbini, A. M., Fulzele, S., & Liou, G. I. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.10.006 · Cited by 30
“All thesemechanisms cause activation of microglial cells and inflammatory responses such as release of free radicals, cytokines, and prostaglandins and complement molecules (Lucas et al., 2006).”
BackgroundBáez-Jurado, E., Guio-Vega, G. P., Hidalgo‐Lanussa, O., González, J., Echeverría, V., Ashraf, G. M., Sahebkar, A., & Barreto, G. E. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1442-9 · Cited by 30
Abdel-Baki, P. M., El-Sherei, M. M., Khaleel, A. E., Abdel‐Aziz, M. M., & Okba, M. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-15361-w · Cited by 30
Wang, C., Zhou, R., Zhang, Z., Jin, Y., Cardona, C. J., & Xing, Z. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000235 · Cited by 30
Manso, H., Krug, T., Sobral, J., Albergaria, I., Gaspar, G., Ferro, J. M., Oliveira, S. A., & Vicente, A. M. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.27 · Cited by 30
“Although there are many inflammatory mediators with detrimental effects, some can be beneficial and others may have dual roles, suggesting a complex orchestration in the acute and recovery phases after stroke (Lucas et al, 2006).”
BackgroundChu, Y., Ko, C., Wang, W., Wang, S., Gean, P., Kuo, Y., & Wang, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9359-z · Cited by 31
“Treatment of mouse primary astrocytes with either TNFα or IL-1β can both lead to increase expression of CEBPD and a decrease in expression of THBS1.”
BackgroundInfluentialBegemann, M., Sargin, D., Rossner, M. J., Bartels, C., Theis, F. J., Wickert, S. P., Stender, N., Fischer, B., Sperling, S., Stawicki, S., et al. (2008) · Molecular Medicine · doi:10.2119/2008-00053.begemann · Cited by 30
“There might well be an interaction between the prostaglandin system found to be episodically regulated here, in the described case, and these inflammatory molecules, also in the CNS (35,39,40).”
BackgroundDeciphering variability in the role of interleukin-1β in Parkinson’s disease
Saghazadeh, A., Ferrari, C. C., & Rezaei, N. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0059 · Cited by 30
Glia–Neuron Interactions in Ictogenesis and Epileptogenesis: Role of Inflammatory Mediators
Vezzani, A., Auvin, S., Ravizza, T., & Aronica, E. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.003.0048 · Cited by 30
Synthesis and anti-inflammatory activity of isoquebecol
Cardinal, S., Paquet-Côté, P.-A., Azelmat, J., Bouchard, C., Grenier, D., & Voyer, N. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.01.050 · Cited by 30
Singh, P., Kaur, S., Kumari, P., Kaur, B., Kaur, M., Singh, G., Bhatti, R., & Bhatti, M. S. S. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00922 · Cited by 30
Chandel, P., Kumar, A., Singla, N., Kumar, A., Singh, G., & Gill, R. K. (2019) · MedChemComm · doi:10.1039/c8md00457a · Cited by 30
Upregulating CD59: a new strategy for protection of neurons from complement-mediated degeneration
Kolev, M. V., Tediose, T., Sivasankar, B., Harris, C. L., Thome, J., Morgan, B. P., & Donev, R. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.52 · Cited by 30
Waindok, P., & Strübe, C. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1537-x · Cited by 29
Fard, M. T., Cribb, L., Nolidin, K., Savage, K. M., Wesnes, K. A., & Stough, C. K. K. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112502 · Cited by 29
Sangaran, P. G., Ibrahim, Z. A., Chik, Z., Mohamed, Z., & Ahmadiani, A. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.598453 · Cited by 29
Denniss, R. J., & Barker, L. A. (2023) · Behavioral Sciences · doi:10.3390/bs13050388 · Cited by 30
Amantadine for Traumatic Brain Injury—Supporting Evidence and Mode of Action
Dekundy, A., Pichler, G., Badry, R., Scheschonka, A., & Danysz, W. (2024) · Biomedicines · doi:10.3390/biomedicines12071558 · Cited by 29
“Both primary and secondary injuries activate the release of cellular mediators (cytokines, prostaglandins, free radicals, and complement) [22].”
BackgroundZhang, X., Luhrs, K. J., Ryff, K. A., Malik, W., Driscoll, M., & Culver, B. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.010 · Cited by 29
Gustafson, S. J., Dunlap, K. L., McGill, C. M., & Kuhn, T. B. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/768101 · Cited by 29
“Hindawi Publishing Corporation Oxidative Medicine and Cellular Longevity Volume 2012, Article ID 768101, 12 pages doi:10.1155/2012/768101 Research Article”
BackgroundInfluentialOki, G., Wada, T., Iba, K., Aiki, H., Sasaki, K., Imai, S.-I., Sohma, H., Matsumoto, K., Yamaguchi, M., Fujimiya, M., et al. (2012) · Pain · doi:10.1016/j.pain.2011.11.008 · Cited by 29
“MT scavenges harmful substances involved in the pathophysiology of neurodegenerative conditions [8,9,24].”
BackgroundMild Systemic Inflammation has a Neuroprotective Effect After Stroke in Rats
Petcu, E. B., Kocher, T., Kuhr, A., Buga, A.-M., Klöting, I., Herndon, J. G., Kessler, C., & Popa‐Wagner, A. (2008) · Current Neurovascular Research · doi:10.2174/156720208786413424 · Cited by 29
Brignone, M. S., Lanciotti, A., Serafini, B., Mallozzi, C., Sbriccoli, M., Veroni, C., Molinari, P., Elorza‐Vidal, X., Petrucci, T. C., Estévez, R., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01657-y · Cited by 29
Ibuprofen fails to prevent brain pathology in a model of neuropsychiatric lupus.
Ballok, D. A., Ma, X., Denburg, J. A., Arsenault, L., & Šakić, B. (2006) · PubMed · Cited by 29
Barth, B. M., Gustafson, S. J., Hankins, J. L., Kaiser, J. M., Haakenson, J. K., KESTER, M. A., & Kuhn, T. B. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.12.020 · Cited by 29
Goshi, N., Lam, D., Bogguri, C., George, V. K., Sebastian, A., Pico, J. E. C., Leon, N. F., Hum, N. R., Weilhammer, D. R., Fischer, N. O., et al. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1512591 · Cited by 28
“Pro-inflammatory cytokines, TNF-α and IL-6, have been linked to numerous CNS disorders including neurodegenerative diseases, autism spectrum disorder, psychiatric disorders, and more recently cognitive impairment associated with long-COVID (Lucas et al., 2006; Fernández-Castañeda et al., 2022).”
Deepika, A., Devi, B. I., Shukla, D. P., Sathyaprabha, T. N., Christopher, R., & Ramesh, S. S. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5151 · Cited by 28
Repeatability and Reproducibility of in-vivo Brain Temperature Measurements
Sharma, A. A., Nenert, R. E., Mueller, C., Maudsley, A. A., Younger, J., & Szaflarski, J. P. (2020) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2020.598435 · Cited by 28
“Neuroinflammation is increasingly implicated in the initiation and maintenance of a number 63 of neurodegenerative diseases, including multiple sclerosis, Alzheimer’s Disease, and epilepsy 64 (Lucas et al., 2006; Amor et al., 2010; Maroso et al., 2010).”
BackgroundRoles of miR-204 in retinal development and maintenance
Bereimipour, A., Najafi, H., Mirsane, E. S., Moradi, S., & Satarian, L. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112737 · Cited by 28
You, W., Li, W., Zhuang, Z., Tang, Y., Lu, H., Ji, X., Shen, W., Shi, J., & Zhou, M. (2012) · Mediators of Inflammation · doi:10.1155/2012/786242 · Cited by 28
Inflammatory activation and cholinergic anti-inflammatory system in eating disorders
MacDowell, K. S., Díaz‐Marsá, M., Güemes, I., Rodríguez, A., Leza, J. C., & Carrasco, J. L. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.04.006 · Cited by 28
“…nervous system activation releases catecholamines, which in turn enhances production of proinflammatory mediators such as cytokines Tumor Necrosis Factor Alpha (TNFa) or Interleukin 1 beta (IL1b), nuclear transcription factors such as kappa B (NFjB) and Nitric Oxide (NO) (Lucas et al., 2006).”
BackgroundAnalgesic, anti-inflammatory and anti-pyretic activities of Caesalpinia decapetala
Parveen, A., Akash, M. S. H., Rehman, K., Mahmood, Q., & Qadir, M. I. (2014) · PubMed Central · doi:10.5681/bi.2014.013 · Cited by 28
Trevisi, E., Moscati, L., & Amadori, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801968-9.00009-x · Cited by 28
Sex differences in sleep apnea and comorbid neurodegenerative diseases
Snyder, B., & Cunningham, R. L. (2017) · Steroids · doi:10.1016/j.steroids.2017.12.006 · Cited by 28
“In addition, treatment with anti-inflammatory agents appear to reduce the risk for neurodegeneration compared to the general population [9,68,92,102].”
Moriyama, M., Hashimoto, A., Satoh, H., Kawabe, K., Mizue, O., Takano, K., & Nakamura, Y. (2018) · International Journal of Inflammation · doi:10.1155/2018/8496973 · Cited by 29
“Recently the crucial role has been recognized for neuroinflammation which is complicated in the pathogenesis of several neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and stroke [1, 2].”
BackgroundMicroRNAs and Regeneration in Animal Models of CNS Disorders
Roitbak, T. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02777-6 · Cited by 28
Zhang, G., Kim, S., Gu, X., Yu, S. P., & Wei, L. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00446-w · Cited by 28
Chiba, T., Ueno, S., Obara, Y., & Nakahata, N. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01250.x · Cited by 28
“Inflammation in the CNS is a key feature associated with neurodegenerative disorders, including multiple sclerosis, Alzheimer’s disease and AIDS-related dementia.([19]) There is substantial evidence from in-vitro studies that cannabinoid receptor agonists exert anti-inflammatory effects by inhibiting pro-inflammatory…”
BackgroundMultiple Therapeutic Effects of Adjunctive Baicalin Therapy in Experimental Bacterial Meningitis
Tang, Y.-J., Zhou, F., Luo, Z.-Q., Li, X.-Z., Yan, H.-M., Wang, M.-J., Huang, F.-R., & Yue, S. (2009) · Inflammation · doi:10.1007/s10753-009-9172-9 · Cited by 28
“Acute bacterial meningitis is a serious and life-threatening infectious disease that requires immediate treatments including etiological and symptomatic treatment [ 2 , 3]. Early and appreciate antibiotic treatment is the cornerstone for effective management of acute bacterial meningitis [3].”
BackgroundInfluentialAnti-inflammatory activity of Ajmodadi Churna extract against acute inflammation in rats
Ram, H. A., Sriwastava, N., Makhija, I. K., & Shreedhara, C. S. (2012) · Journal of Ayurveda and Integrative Medicine · doi:10.4103/0975-9476.93946 · Cited by 28
Neuroprotection of Early Locomotor Exercise Poststroke: Evidence From Animal Studies
Zhang, P., Xianglei, J., Hongbo, Y., Zhang, J., & Xu, C. (2015) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2015.39 · Cited by 28
S100A8 Promotes Inflammation via Toll-Like Receptor 4 After Experimental Traumatic Brain Injury
He, G., Zhao, C., Wu, D.-G., Cheng, H., Sun, L., Zhang, D., Yang, X., Fan, X.-R., Di, G., & Jiang, X. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.616559 · Cited by 27
Alnuqaydan, A. M., Almutary, A. G., Bhat, G. R., Mir, T. A., Wani, S. I., Rather, M. Y., Mir, S. A., Alshehri, B., Alnasser, S. M., Zainy, F. M. A., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061256 · Cited by 27
“The excessive inflammatory response in the form of activation of immune cells and proinflammatory mediators often aggravates and causes tissue damage [12].”
BackgroundGonzález-May, C. A., Castillo, M. D. R. B., Rios, J. H. P., Tintoré, S. G., Pérez-Izquierdo, O., & Aranda-González, I. I. (2023) · Nutrition Research · doi:10.1016/j.nutres.2023.10.004 · Cited by 27
Liu, P., Li, Y., Quartermain, D., Boutajangout, A., & Ji, Y. (2013) · Brain Research · doi:10.1016/j.brainres.2013.05.032 · Cited by 27
“Accumulating data suggest that the neuroinflammatory response induced by TBI is characterized by microglia and astrocytic activation, and acute up-regulation of proinflammatory cytokines such as interleukin (IL)-1β, tumor necrosis factor (TNF) α, and IL-6 (Lucas et al., 2006; MorgantiKossmann et al., 2001; Schmidt et…”
BackgroundTajiri, N., Hernandez, D., Acosta, S., Shinozuka, K., Ishikawa, H., Ehrhart, J. C., Diamandis, T., Gonzales-Portillo, C., Borlongan, M. C., Tan, J., et al. (2014) · Brain Research · doi:10.1016/j.brainres.2014.02.041 · Cited by 27
Yan, T., Ye, X., Chopp, M., Zacharek, A., Ning, R., Venkat, P., Roberts, C. J., Lü, M., & Chen, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081199 · Cited by 27
“Neuroinflammatory responses activate glial cells by triggering inflammatory mediators like cytokines, prostaglandins and free radicals that can act on the immune system [58].”
BackgroundIntegrated Stress Response as a Therapeutic Target for CNS Injuries
Romero‐Ramírez, L., Nieto‐Sampedro, M., & Barreda-Manso, M. A. (2017) · BioMed Research International · doi:10.1155/2017/6953156 · Cited by 27
“The proinflammatory mediators induce the activation and recruitment of leukocytes to the inflammation site in the CNS parenchyma [10, 13].”
BackgroundBinge ethanol exposure induces endoplasmic reticulum stress in the brain of adult mice
Wang, Y., Wang, X., Li, H., Xu, M., Frank, J. A., & Luo, J. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.08.006 · Cited by 27
“It has been suggested that inflammation and oxidative stress play a pivotal role in ethanol-induced neurodegeneration (Lucas et al., 2006; Qin et al., 2008; Zou and Crews, 2010; Qin and Crews, 2012).”
Mahmoudi, N. E., Rastoldo, G., Marouane, E., Péricat, D., Watabe, I., Tonetto, A., Hautefort, C., Chabbert, C., Sargolini, F., & Tighilet, B. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02222-y · Cited by 27
Bibliometric analysis of tumor necrosis factor in post-stroke neuroinflammation from 2003 to 2021
Zhao, Y., Zhu, Q., Bi, C., Yuan, J., Chen, Y., & Xiao-fei, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1040686 · Cited by 27
“Additionally, the U.S. had the top-ranked Hindex (84), which was twofold higher than South Korea (33) and Canada (30).”
BackgroundInfluentialScaini, G., Morais, M. O. D. S., Galant, L. S., Vuolo, F. S., Dall’Igna, D. M., Pasquali, M. A. D. B., Ramos, V. D. M., Gelain, D. P., Moreira, J. C. F., Schuck, P. F., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8618-0 · Cited by 27
“The resulting alterations in BBB permeability may contribute to secondary brain injury through abnormal passage of blood-borne substances into the CNS influencing neuronal vulnerability [47, 48].”
BackgroundPostnatal development of lipopolysaccharide-induced inflammatory response in the brain
Ortega, A., Jadeja, V., & Zhou, H. (2010) · Inflammation Research · doi:10.1007/s00011-010-0252-y · Cited by 27
“Sepsis and septic shock often lead to neuroinflammation which involves many inflammatory mediators, with the pro-inflammatory cytokines playing an important role in initiating the inflammatory cascade and chemokines as one of the major soluble products that induce the recruitment of immune cells to the brain parenchym…”
BackgroundEkmark‐Lewén, S., Flygt, J., Fridgeirsdottir, G. A., Kiwanuka, O., Hånell, A., Meyerson, B. J., Mir, A. K., Gram, H., Lewén, A., Clausen, F., et al. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13190 · Cited by 26
“Microglia/macrophage cell counts and ventricular volume The number of microglia/macrophages was analysed because they may constitute a first line of defence after TBI, and microglia can, when activated, release IL-1b (Lucas et al., 2006; Loane & Byrnes, 2010).”
BackgroundRemote effects on the striatal dopamine system after fluid percussion injury
Huang, E. Y., Tsai, T.-H., Kuo, T., Tsai, J.-J., Tsui, P.-F., Chou, Y., Ma, H.-I., Chiang, Y. H., & Chen, Y.-H. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.03.033 · Cited by 26
Lorente, L., Martin, M. M. I. D. O., González-Rivero, A. F., Ramos, L., Argüeso, M., Cáceres, J. J., Solé‐Violán, J., Serrano, N. A., Rodriguez, S., Jiménez, A., et al. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.07.034 · Cited by 26
“injury and is due to different mechanisms [2,3].”
BackgroundNew-onset seizure in HIV-infected adult Zambians: A search for causes and consequences
Siddiqi, O. K., Elafros, M. A., Bositis, C. M., Koralnik, I. J., Theodore, W. H., Okulicz, J. F., Kalungwana, L., Potchen, M. J., Sikazwe, I. T., & Birbeck, G. L. (2016) · Neurology · doi:10.1212/wnl.0000000000003538 · Cited by 26
“HIV alone is known to cause inflammation within the brain,(17,18) which may further predispose to or precipitate seizure activity.(19,20) In a study of 37 South African HIV-infected patients with new-onset seizure, 27% had no identifiable cause,(21) and demonstrated detectable CSF HIV viral loads.”
Background
Metadata
- Authors
- Lucas, S., Rothwell, N. J., & Gibson, R. M.
- Affiliations
- University of Manchester (GB)
- HSE Science and Research Centre (GB)
- Corresponding author
- Rothwell, Nancy J
- ORCID
- Rothwell, Nancy J
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2006-01
- Volume
- 147
- Issue
- S1
- Pages
- S232-40
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1760754
- OpenAlex
- W1594425991
- Cited by
- 1,272
- References
- 41
- Citations by year
- 2026: 12 · 2025: 37 · 2024: 32 · 2023: 57 · 2022: 65 · 2021: 69 · 2020: 62 · 2019: 80 · 2018: 67 · 2017: 67 · 2016: 60 · 2015: 89 · 2014: 77 · 2013: 79 · 2012: 62
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Keywords
- neuroinflammation, central nervous system injury, immune privilege, inflammatory cytokines, prostaglandins, free radicals, complement system, chemokines, glial activation, interleukin-1, interleukin-1 receptor antagonist, stroke, traumatic brain injury, Alzheimer's disease, anti-inflammatory therapy, neurodegeneration, aging
- MeSH terms
- Acute Disease, Animals, Brain, Central Nervous System Diseases, Chronic Disease, Craniocerebral Trauma, Humans, Inflammation, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.